However, in advanced disease cases, many ERα-positive tumours progress into an estrogen-independent and antiestrogen-resistant phenotype, a hallmark of breast cancer with poor prognosis, often resulting in tumour progression and mortality [11]. This evidence concerns the gene ESR1 and breast cancer.